TNF and glomerulonephritis: As it is known that glomerular visceral epithelial cells can produce TNFα [55], the interaction between TNFα and anti TNFα antibodies (produced as a consequence of infliximab therapy) can result in glomerulonephritis and membranous nephropathy.